MedPath

Oxytocin vs carbetocin for the prevention of postpartum hemorrhage in high risk patients

Phase 3
Not yet recruiting
Conditions
Health Condition 1: -
Registration Number
CTRI/2023/11/060324
Lead Sponsor
Dr Vaishnavi Watane
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients having high risk for postpartum hemorrhage according to risk assessment score

Exclusion Criteria

no exclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath